The divergent genetic landscapes in HPV+ and HPV-negative HNSCC are the result of two distinct oncogenic pathways, with HPV-negative cancers frequently displaying mutations of several tumor suppressors such as p53, which is mutated in the vast majority of HPV-negative HNSCC [66,67,68]. Here, TP53 is linked to cancer.